- Home
- CVAC vs LENZ Comparison
CVAC vs LENZ Comparison
Compare CVAC & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CVAC | LENZ |
|---|---|---|
| Founded | 2000 | 2019 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 852.0M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CVAC | LENZ |
|---|---|---|
| Price | $5.12 | $26.72 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $6.83 | ★ $56.25 |
| AVG Volume (30 Days) | ★ 1.7M | 966.7K |
| Earning Date | 11-24-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 94.02 | N/A |
| EPS | ★ 0.94 | N/A |
| Revenue | ★ $83,000,117.00 | $17,500,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $23.40 | $204.72 |
| P/E Ratio | $5.47 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.48 | $16.54 |
| 52 Week High | $5.72 | $50.40 |
Technical Indicators
Market Signals| Indicator | CVAC | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 43.12 | 41.96 |
| Support Level | $5.11 | $27.07 |
| Resistance Level | $5.23 | $29.02 |
| Average True Range (ATR) | 0.13 | 2.08 |
| MACD | -0.01 | 0.28 |
| Stochastic Oscillator | 30.83 | 25.53 |
Price Performance
Historical ComparisonAbout CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.